Ads
related to: moderna stock
Search results
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 4 days agoThe institutional investor owned 3,028 shares of the company’s stock after selling 261 shares during the quarter. Wealthspire Advisors LLC’s holdings in Moderna< ...
Novavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall By Investing.com
Investing.com· 6 days agoNovavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks· 3 days agoFree Report) is one of the stocks most watched by Zacks.com visitors lately. Over the past month, shares of this biotechnology company have returned +11.6%, compared to the Zacks S&P 500 composite's ...
Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares
ETF DAILY NEWS· 3 days agoFollowing the completion of the transaction, the director now owns 2,011,931 shares in the company, valued at approximately $244,811,764.08. On Wednesday, May 1st, Noubar Afeyan sold 15,000 ...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 5 days agoModerna stock toppled Friday after the Food and Drug Administration delayed an approval decision on...
Post-pandemic problems: These stocks are still down more than 50 percent from their Covid highs
Bankrate via AOL· 12 hours agoIts shares traded as low as $3.55 in December 2022. Covid high stock price: $376.83 Current stock...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 6 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 7 days agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...